99 related articles for article (PubMed ID: 15151207)
1. Microdissection-based genotyping assists discrimination of reactive gliosis from glioma.
Finkelstein SD; Mohan D; Hamilton RL; Sasatomi E; Swalsky PA; Lieberman FS
Am J Clin Pathol; 2004 May; 121(5):671-8. PubMed ID: 15151207
[TBL] [Abstract][Full Text] [Related]
2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
3. Microdissection genotyping analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
Tse DT; Finkelstein SD; Benedetto P; Dubovy S; Schiffman J; Feuer WJ
Am J Ophthalmol; 2006 Jan; 141(1):54-61. PubMed ID: 16386976
[TBL] [Abstract][Full Text] [Related]
4. Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes.
Capper D; Sahm F; Hartmann C; Meyermann R; von Deimling A; Schittenhelm J
Am J Surg Pathol; 2010 Aug; 34(8):1199-204. PubMed ID: 20661018
[TBL] [Abstract][Full Text] [Related]
5. Comparison of numerical change of epidermal growth factor receptor gene among pre- and postradiation glioma, and gliosis, and its clinical use.
Okada Y; Ohno C; Ueki K; Ogino M; Kawamoto S; Kim P
Brain Tumor Pathol; 2007; 24(1):15-8. PubMed ID: 18095139
[TBL] [Abstract][Full Text] [Related]
6. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].
Born PW; Broholm H; Laursen H
Ugeskr Laeger; 2006 Oct; 168(44):3813-6. PubMed ID: 17118240
[TBL] [Abstract][Full Text] [Related]
7. Gliosis versus glioma?: don't grade until you know.
Rivera-Zengotita M; Yachnis AT
Adv Anat Pathol; 2012 Jul; 19(4):239-49. PubMed ID: 22692287
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations of protein-o-mannosyltransferase-1 in glioneuronal and glial brain tumors with subarachnoid spread.
Snoei J; Urbach H; Engels G; Fassunke J; von Lehe M; Becker AJ; Majores M
Neuropathology; 2009 Apr; 29(2):116-24. PubMed ID: 18647264
[TBL] [Abstract][Full Text] [Related]
9. High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusion.
Law M; Brodsky JE; Babb J; Rosenblum M; Miller DC; Zagzag D; Gruber ML; Johnson G
J Magn Reson Imaging; 2007 Jun; 25(6):1113-9. PubMed ID: 17520715
[TBL] [Abstract][Full Text] [Related]
10. Microdissection-based mutational genotyping of serous borderline tumors of the ovary.
Krishnamurti U; Sasatomi E; Swalsky PA; Jones MW; Finkelstein SD
Int J Gynecol Pathol; 2005 Jan; 24(1):56-61. PubMed ID: 15626917
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy.
Mariani L; Deiana G; Vassella E; Fathi AR; Murtin C; Arnold M; Vajtai I; Weis J; Siegenthaler P; Schobesberger M; Reinert MM
J Clin Oncol; 2006 Oct; 24(29):4758-63. PubMed ID: 16966689
[TBL] [Abstract][Full Text] [Related]
12. Microdissection genotyping of gliomas: therapeutic and prognostic considerations.
Mohan D; Finkelstein SD; Swalsky PA; Sasatomi E; Wiley C; Hamilton RL; Lieberman F; Couce ME
Mod Pathol; 2004 Nov; 17(11):1346-58. PubMed ID: 15181452
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors.
Ren ZP; Olofsson T; Qu M; Hesselager G; Soussi T; Kalimo H; Smits A; Nistér M
J Neuropathol Exp Neurol; 2007 Oct; 66(10):944-54. PubMed ID: 17917588
[TBL] [Abstract][Full Text] [Related]
14. Accurate genotyping from paraffin-embedded normal tissue adjacent to breast cancer.
Xie B; Freudenheim JL; Cummings SS; Singh B; He H; McCann SE; Moysich KB; Shields PG
Carcinogenesis; 2006 Feb; 27(2):307-10. PubMed ID: 16113052
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation and allelic losses on chromosome arm 14q in oligodendroglial tumours.
Felsberg J; Yan PS; Huang TH; Milde U; Schramm J; Wiestler OD; Reifenberger G; Pietsch T; Waha A
Neuropathol Appl Neurobiol; 2006 Oct; 32(5):517-24. PubMed ID: 16972885
[TBL] [Abstract][Full Text] [Related]
16. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M
Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124
[TBL] [Abstract][Full Text] [Related]
17. Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder.
Cheng L; MacLennan GT; Zhang S; Wang M; Pan CX; Koch MO
Cancer; 2004 Jul; 101(1):183-8. PubMed ID: 15222005
[TBL] [Abstract][Full Text] [Related]
18. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
19. Tissue array analysis for the differentiation of gliosis from gliomas.
Medina Villaamil V; Alvarez García A; Aparicio Gallego G; Díaz Prado S; Rivas López LA; Santamarina Caínzos I; Valladares Ayerbes M; Antón Aparicio LM
Mol Med Rep; 2011; 4(3):451-7. PubMed ID: 21468591
[TBL] [Abstract][Full Text] [Related]
20. Clinical, histological, and immunohistochemical features predicting 1p/19q loss of heterozygosity in oligodendroglial tumors.
Kim SH; Kim H; Kim TS
Acta Neuropathol; 2005 Jul; 110(1):27-38. PubMed ID: 15920661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
